Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbations

Brain Research

Volumn 1648, Issue , 2016, Pages 603-616

  Mollereau, B ^a   Rzechorzek, N M ^b,c   Roussel, B D ^d   Sedru, M ^a   Van den Brink, D M ^a   Bailly Maitre, B ^e   Palladino, F ^a   Medinas, D B ^f,g,h   Domingos, P M ^j   Hunot, S ^d,k,l,m   Chandran, S ^b   Birman, S ⁿ   Baron, T ^o   Vivien, D ^d   Duarte, C B ^p   Ryoo, H D ^q   Steller, H ^r   Urano, F ^s   Chevet, E ^t,u   Kroemer, G ^{d,l,v,w,x,y,z}   Ciechanover, A ^aa   Calabrese, E J ^ab   Kaufman, R J ^ac   Hetz, C ^f,g,h,i   more..

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d INSERM   (France)

^e CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^f UNIVERSITY OF CHILE   (Chile)

^g UNIVERSITY OF CHILE   (Chile)

^h Universidad de Chile and Geroscience Center for Brain Health and Metabolism   (Chile)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^k CNRS   (France)

^l SORBONNE UNIVERSITÉ   (France)

^m INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

ⁿ PSL RESEARCH UNIVERSITY   (France)

^o FRENCH AGENCY FOR FOOD   (France)

^p UNIVERSITY OF COIMBRA   (Portugal)

^q NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r ROCKEFELLER UNIVERSITY   (United States)

^s WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITÉ DE RENNES 1   (France)

^u Nuclear Medicine Department   (France)

^v CENTRE DE RECHERCHE DES CORDELIERS   (France)

^w INSTITUT GUSTAVE ROUSSY   (France)

^x UNIVERSITÉ PARIS DESCARTES   (France)

^y HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^z KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^aa TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^ab UNIVERSITY OF MASSACHUSETTS   (United States)

^ac BURNHAM INSTITUTE   (United States)

more..

Author keywords

Autophagy; ER stress; Glioblastoma; Hormesis; Ischemia; Parkinson s disease; Proteasome; Wolfram syndrome

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; PROTEASOME; UBIQUITIN;

ADAPTATION; AUTOPHAGY; BRAIN CANCER; BRAIN ISCHEMIA; GLIOBLASTOMA; GLIOMA; HUMAN; ISCHEMIC PRECONDITIONING; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; REPERFUSION INJURY; REVIEW; STRESS; UNFOLDED PROTEIN RESPONSE; WOLFRAM SYNDROME; ANIMAL; COMPLICATION; ENDOPLASMIC RETICULUM STRESS; METABOLISM; PHYSIOLOGY; PROTEOSTASIS DEFICIENCY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; ENDOPLASMIC RETICULUM STRESS; HUMANS; NERVOUS SYSTEM DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOSTASIS DEFICIENCIES; SIGNAL TRANSDUCTION; UBIQUITIN; UNFOLDED PROTEIN RESPONSE;

EID: 84960193866     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.02.033     Document Type: Review

References (205)

1. Abisambra, J.F., Jinwal, U.K., Blair, L.J., O׳Leary, J.C. 3rd, Li, Q., Brady, S., Wang, L., Guidi, C.E., Zhang, B., Nordhues, B.A., Cockman, M., Suntharalingham, A., Li, P., Jin, Y., Atkins, C.A., Dickey, C.A., Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation. J. Neurosci. 33 (2013), 9498–9507.
2. Anderson, L.L., Mao, X., Scott, B.A., Crowder, C.M., Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases. Science 323 (2009), 630–633.
3. Andre, R., Tabrizi, S.J., Misfolded PrP and a novel mechanism of proteasome inhibition. Prion 6 (2012), 32–36.
4. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., Finkbeiner, S., Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004), 805–810.
5. Arrasate, M., Finkbeiner, S., Protein aggregates in Huntington׳s disease. Exp. Neurol. 238 (2012), 1–11.
6. Auf, G., Jabouille, A., Guerit, S., Pineau, R., Delugin, M., Bouchecareilh, M., Magnin, N., Favereaux, A., Maitre, M., Gaiser, T., von Deimling, A., Czabanka, M., Vajkoczy, P., Chevet, E., Bikfalvi, A., Moenner, M., Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc. Natl. Acad. Sci. USA 107 (2010), 15553–15558.
7. Auf, G., Jabouille, A., Delugin, M., Guerit, S., Pineau, R., North, S., Platonova, N., Maitre, M., Favereaux, A., Vajkoczy, P., Seno, M., Bikfalvi, A., Minchenko, D., Minchenko, O., Moenner, M., High epiregulin expression in human U87 glioma cells relies on IRE1alpha and promotes autocrine growth through EGF receptor. BMC Cancer, 13, 2013, 597.
8. Back, S.H., Scheuner, D., Han, J., Song, B., Ribick, M., Wang, J., Gildersleeve, R.D., Pennathur, S., Kaufman, R.J., Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. Cell. Metab. 10 (2009), 13–26.
9. Bailly-Maitre, B., Fondevila, C., Kaldas, F., Droin, N., Luciano, F., Ricci, J.E., Croxton, R., Krajewska, M., Zapata, J.M., Kupiec-Weglinski, J.W., Farmer, D., Reed, J.C., Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 103 (2006), 2809–2814.
10. Balch, W.E., Morimoto, R.I., Dillin, A., Kelly, J.W., Adapting proteostasis for disease intervention. Science 319 (2008), 916–919.
11. Barrett, T.G., Bundey, S.E., Macleod, A.F., Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346 (1995), 1458–1463.
12. Bauereis, B., Haskins, W.E., Lebaron, R.G., Renthal, R., Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson׳s disease. Neurosci. Lett. 488 (2011), 11–16.
13. Berti, R., Williams, A.J., Velarde, L.C., Moffett, J.R., Elliott, P.J., Adams, J., Yao, C., Dave, J.R., Tortella, F.C., Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat. Neurotox. Res. 5 (2003), 505–514.
14. Bevers, M.B., Neumar, R.W., Mechanistic role of calpains in postischemic neurodegeneration. J. Cereb. Blood Flow Metab. 28 (2008), 655–673.
15. Bonnet Wersinger, D., Benkafadar, N., Jagodzinska, J., Hamel, C., Tanizawa, Y., Lenaers, G., Delettre, C., Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice. Plos One, 9, 2014, e97222.
16. Bouman, L., Schlierf, A., Lutz, A.K., Shan, J., Deinlein, A., Kast, J., Galehdar, Z., Palmisano, V., Patenge, N., Berg, D., Gasser, T., Augustin, R., Trumbach, D., Irrcher, I., Park, D.S., Wurst, W., Kilberg, M.S., Tatzelt, J., Winklhofer, K.F., Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 18 (2011), 769–782.
17. Boyce, M., Bryant, K.F., Jousse, C., Long, K., Harding, H.P., Scheuner, D., Kaufman, R.J., Ma, D., Coen, D.M., Ron, D., Yuan, J., A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science. 307 (2005), 935–939.
18. Bull, R., Finkelstein, J.P., Galvez, J., Sanchez, G., Donoso, P., Behrens, M.I., Hidalgo, C., Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor channels from rat brain cortex. J. Neurosci. 28 (2008), 9463–9472.
19. Calabrese, E.J., Hormesis: from mainstream to therapy. J. Cell Commun. Signal 8 (2014), 289–291.
20. Calabrese, E.J., Preconditioning is hormesis part I: Documentation, dose–response features and mechanistic foundations. Pharmacol Res. 110 (2016), 242–264.
21. Calabrese, E.J., Preconditioning is hormesis part II: How the conditioning dose mediates protection: Dose optimization within temporal and mechanistic frameworks. Pharmacol Res. 110 (2016), 265–275.
22. Caldeira, M.V., Salazar, I.L., Curcio, M., Canzoniero, L.M., Duarte, C.B., Role of the ubiquitin–proteasome system in brain ischemia: friend or foe?. Prog. Neurobiol. 112 (2014), 50–69.
23. Carloni, S., Buonocore, G., Balduini, W., Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol. Dis. 32 (2008), 329–339.
24. Carloni, S., Albertini, M.C., Galluzzi, L., Buonocore, G., Proietti, F., Balduini, W., Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia-ischemia: role of protein synthesis and autophagic pathways. Exp. Neurol. 255 (2014), 103–112.
25. Castillo, K., Rojas-Rivera, D., Lisbona, F., Caballero, B., Nassif, M., Court, F.A., Schuck, S., Ibar, C., Walter, P., Sierralta, J., Glavic, A., Hetz, C., BAX inhibitor-1 regulates autophagy by controlling the IRE1alpha branch of the unfolded protein response. Embo J. 30:21 (2011), 4465–4478.
26. Castillo, V., Mercado, G., Hetz, C., Gene therapy in Parkinson׳s disease: targeting the endplasmic reticulum proteostasis network. Neural Regen. Res. 10 (2015), 1053–1054.
27. Chae, H.J., Ke, N., Kim, H.R., Chen, S., Godzik, A., Dickman, M., Reed, J.C., Evolutionarily conserved cytoprotection provided by Bax Inhibitor-1 homologs from animals, plants, and yeast. Gene 323 (2003), 101–113.
28. Chae, H.J., Kim, H.R., Xu, C., Bailly-Maitre, B., Krajewska, M., Krajewski, S., Banares, S., Cui, J., Digicaylioglu, M., Ke, N., Kitada, S., Monosov, E., Thomas, M., Kress, C.L., Babendure, J.R., Tsien, R.Y., Lipton, S.A., Reed, J.C., BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol. Cell. 15 (2004), 355–366.
29. Chevet, E., Hetz, C., Samali, A., Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov. 5 (2015), 586–597.
30. Chevilley, A., Lesept, F., Lenoir, S., Ali, C., Parcq, J., Vivien, D., Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Front. Cell Neurosci., 9, 2015, 415.
31. Choi, H.A., Badjatia, N., Mayer, S.A., Hypothermia for acute brain injury–mechanisms and practical aspects. Nat. Rev. Neurol. 8 (2012), 214–222.
32. Chung, C.Y., Khurana, V., Auluck, P.K., Tardiff, D.F., Mazzulli, J.R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., Mungenast, A.E., Muffat, J., Mitalipova, M., Pluth, M.D., Jui, N.T., Schule, B., Lippard, S.J., Tsai, L.H., Krainc, D., Buchwald, S.L., Jaenisch, R., Lindquist, S., Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342 (2013), 983–987.
33. Ciechanover, A., The unravelling of the ubiquitin system. Nat. Rev. Mol. Cell Biol. 16 (2015), 322–324.
34. Ciechanover, A., Kwon, Y.T., Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp. Mol. Med., 47, 2015, e147.
35. Clague, M.J., Urbe, S., Ubiquitin: same molecule, different degradation pathways. Cell 143 (2010), 682–685.
36. Cnop, M., Ladriere, L., Hekerman, P., Ortis, F., Cardozo, A.K., Dogusan, Z., Flamez, D., Boyce, M., Yuan, J., Eizirik, D.L., Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J. Biol. Chem. 282 (2007), 3989–3997.
37. Coelho, D.S., Domingos, P.M., Physiological roles of regulated Ire1 dependent decay. Front. Genet., 5, 2014, 76.
38. Colla, E., Coune, P., Liu, Y., Pletnikova, O., Troncoso, J.C., Iwatsubo, T., Schneider, B.L., Lee, M.K., Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J. Neurosci. 32 (2012), 3306–3320.
39. Conway, K.A., Harper, J.D., Lansbury, P.T., Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4 (1998), 1318–1320.
40. Cooper, A.A., Gitler, A.D., Cashikar, A., Haynes, C.M., Hill, K.J., Bhullar, B., Liu, K., Xu, K., Strathearn, K.E., Liu, F., Cao, S., Caldwell, K.A., Caldwell, G.A., Marsischky, G., Kolodner, R.D., Labaer, J., Rochet, J.C., Bonini, N.M., Lindquist, S., Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson׳s models. Science 313 (2006), 324–328.
41. Coulom, H., Birman, S., Chronic exposure to rotenone models sporadic Parkinson׳s disease in Drosophila melanogaster. J. Neurosci. 24 (2004), 10993–10998.
42. Credle, J.J., Forcelli, P.A., Delannoy, M., Oaks, A.W., Permaul, E., Berry, D.L., Duka, V., Wills, J., Sidhu, A., alpha-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson׳s disease. Neurobiol. Dis. 76 (2015), 112–125.
43. Dadey, D.Y., Kapoor, V., Khudanyan, A., Urano, F., Kim, A.H., Thotala, D., Hallahan, D.E., The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma. Oncotarget 7 (2016), 2080–2092.
44. DeGracia, D.J., Montie, H.L., Cerebral ischemia and the unfolded protein response. J. Neurochem. 91 (2004), 1–8.
45. Dejeans, N., Pluquet, O., Lhomond, S., Grise, F., Bouchecareilh, M., Juin, A., Meynard-Cadars, M., Bidaud-Meynard, A., Gentil, C., Moreau, V., Saltel, F., Chevet, E., Autocrine control of glioma cells adhesion and migration through IRE1alpha-mediated cleavage of SPARC mRNA. J. Cell. Sci. 125 (2012), 4278–4287.
46. Dennissen, F.J., Kholod, N., van Leeuwen, F.W., The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?. Prog. Neurobiol. 96 (2012), 190–207.
47. Ding, D., Endovascular mechanical thrombectomy for acute ischemic stroke: a new standard of care. J. Stroke 17 (2015), 123–126.
48. Doeppner, T.R., Mlynarczuk-Bialy, I., Kuckelkorn, U., Kaltwasser, B., Herz, J., Hasan, M.R., Hermann, D.M., Bahr, M., The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain 135 (2012), 3282–3297.
49. Doeppner, T.R., Doehring, M., Bretschneider, E., Zechariah, A., Kaltwasser, B., Muller, B., Koch, J.C., Bahr, M., Hermann, D.M., Michel, U., MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation. Acta Neuropathol. 126 (2013), 251–265.
50. Doeppner, T.R., Kaltwasser, B., Kuckelkorn, U., Henkelein, P., Bretschneider, E., Kilic, E., Hermann, D.M., Systemic proteasome inhibition induces sustained post-stroke neurological recovery and neuroprotection via mechanisms involving reversal of peripheral immunosuppression and preservation of blood-brain-barrier integrity. Mol. Neurobiol., 2015 Epub ahead of print.
51. Doyle, K.P., Simon, R.P., Stenzel-Poore, M.P., Mechanisms of ischemic brain damage. Neuropharmacology 55 (2008), 310–318.
52. Drogat, B., Auguste, P., Nguyen, D.T., Bouchecareilh, M., Pineau, R., Nalbantoglu, J., Kaufman, R.J., Chevet, E., Bikfalvi, A., Moenner, M., IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-a expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res. 67 (2007), 6700–6707.
53. Egawa, N., Yamamoto, K., Inoue, H., Hikawa, R., Nishi, K., Mori, K., Takahashi, R., The endoplasmic reticulum stress sensor, ATF6alpha, protects against neurotoxin-induced dopaminergic neuronal death. J. Biol. Chem. 286 (2011), 7947–7957.
54. Finley, D., Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78 (2009), 477–513.
55. Fonseca, S.G., Burcin, M., Gromada, J., Urano, F., Endoplasmic reticulum stress in beta-cells and development of diabetes. Curr. Opin. Pharmacol. 9 (2009), 763–770.
56. Fonseca, S.G., Ishigaki, S., Oslowski, C.M., Lu, S., Lipson, K.L., Ghosh, R., Hayashi, E., Ishihara, H., Oka, Y., Permutt, M.A., Urano, F., Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J. Clin. Investig. 120 (2010), 744–755.
57. Fouillet, A., Levet, C., Virgone, A., Robin, M., Dourlen, P., Rieusset, J., Belaidi, E., Ovize, M., Touret, M., Nataf, S., Mollereau, B., ER stress inhibits neuronal death by promoting autophagy. Autophagy 8 (2012), 915–926.
58. Fredriksson, L., Li, H., Fieber, C., Li, X., Eriksson, U., Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J. 23 (2004), 3793–3802.
59. Garcia-Rocha, M., Avila, J., Armas-Portela, R., Tissue-type plasminogen activator (tPA) is the main plasminogen activator associated with isolated rat nerve growth cones. Neurosci. Lett. 180 (1994), 123–126.
60. Gitler, A.D., Bevis, B.J., Shorter, J., Strathearn, K.E., Hamamichi, S., Su, L.J., Caldwell, K.A., Caldwell, G.A., Rochet, J.C., McCaffery, J.M., Barlowe, C., Lindquist, S., The Parkinson׳s disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA. 105 (2008), 145–150.
61. Glickman, M.H., Ciechanover, A., The ubiquitin–proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002), 373–428.
62. Goldberg, A.L., Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003), 895–899.
63. Gorbatyuk, M.S., Shabashvili, A., Chen, W., Meyers, C., Sullivan, L.F., Salganik, M., Lin, J.H., Lewin, A.S., Muzyczka, N., Gorbatyuk, O.S., Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther. 20 (2012), 1327–1337.
64. Grune, T., Jung, T., Merker, K., Davies, K.J., Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ׳aggresomes׳ during oxidative stress, aging, and disease. Int. J Biochem. Cell. Biol. 36 (2004), 2519–2530.
65. Gupta, S., Deepti, A., Deegan, S., Lisbona, F., Hetz, C., Samali, A., HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction. Plos. Biol., 8, 2010, e1000410.
66. Hamed, H.A., Yacoub, A., Park, M.A., Eulitt, P., Sarkar, D., Dimitrie, I.P., Chen, C.S., Grant, S., Curiel, D.T., Fisher, P.B., Dent, P., OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biol. Ther. 9 (2010), 526–536.
67. Han, J., Back, S.H., Hur, J., Lin, Y.H., Gildersleeve, R., Shan, J., Yuan, C.L., Krokowski, D., Wang, S., Hatzoglou, M., Kilberg, M.S., Sartor, M.A., Kaufman, R.J., ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell. Biol. 15 (2013), 481–490.
68. Han, J., Song, B., Kim, J., Kodali, V.K., Pottekat, A., Wang, M., Hassler, J., Wang, S., Pennathur, S., Back, S.H., Katze, M.G., Kaufman, R.J., Antioxidants complement the requirement for protein chaperone function to maintain beta-cell function and glucose homeostasis. Diabetes 64 (2015), 2892–2904.
69. Hara, H., Kamiya, T., Adachi, T., Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity. Neurochem. Int. 58 (2011), 35–43.
70. Harding, H.P., Zhang, Y., Scheuner, D., Chen, J.J., Kaufman, R.J., Ron, D., Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2alpha) dephosphorylation in mammalian development. Proc. Natl. Acad. Sci. USA 106 (2009), 1832–1837.
71. Hardingham, G.E., Bading, H., Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11 (2010), 682–696.
72. Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K.R., MacLeod, G., Mis, M., Zimmermann, M., Fradet-Turcotte, A., Sun, S., Mero, P., Dirks, P., Sidhu, S., Roth, F.P., Rissland, O.S., Durocher, D., Angers, S., Moffat, J., High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163 (2015), 1515–1526.
73. Hashida, K., Kitao, Y., Sudo, H., Awa, Y., Maeda, S., Mori, K., Takahashi, R., Iinuma, M., Hori, O., ATF6alpha promotes astroglial activation and neuronal survival in a chronic mouse model of Parkinson׳s disease. Plos One, 7, 2012, e47950.
74. Henderson, B.J., Lester, H.A., Inside-out neuropharmacology of nicotinic drugs. Neuropharmacology 96 (2015), 178–193.
75. Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., Martinez, G., Cuervo, A.M., Brown, R.H., Glimcher, L.H., XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 23 (2009), 2294–2306.
76. Hetz, C., Martinon, F., Rodriguez, D., Glimcher, L.H., The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol. Rev. 91 (2011), 1219–1243.
77. Hetz, C., Chevet, E., Harding, H.P., Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12 (2013), 703–719.
78. Hetz, C., Mollereau, B., Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15 (2014), 233–249.
79. Hetz, C., Chevet, E., Oakes, S.A., Proteostasis control by the unfolded protein response. Nat. Cell. Biol. 17 (2015), 829–838.
80. Hirsch, E.C., Jenner, P., Przedborski, S., Pathogenesis of Parkinson׳s disease. Mov. Disord. 28 (2013), 24–30.
81. Hochrainer, K., Jackman, K., Anrather, J., Iadecola, C., Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion. Stroke 43 (2012), 2229–2235.
82. Hofmeijer, J., van Putten, M.J., Ischemic cerebral damage: an appraisal of synaptic failure. Stroke 43 (2012), 607–615.
83. Hoozemans, J.J., van Haastert, E.S., Eikelenboom, P., de Vos, R.A., Rozemuller, J.M., Scheper, W., Activation of the unfolded protein response in Parkinson׳s disease. Biochem. Biophys. Res. Commun. 354 (2007), 707–711.
84. Hoozemans, J.J., van Haastert, E.S., Nijholt, D.A., Rozemuller, A.J., Scheper, W., Activation of the unfolded protein response is an early event in Alzheimer׳s and Parkinson׳s disease. Neurodegener. Dis. 10 (2012), 212–215.
85. Hou, X., Liu, Y., Liu, H., Chen, X., Liu, M., Che, H., Guo, F., Wang, C., Zhang, D., Wu, J., Shen, C., Li, C., Peng, F., Bi, Y., Yang, Z., Yang, G., Ai, J., Gao, X., Zhao, S., PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2׳s mitochondria translocation. Sci. Rep., 5, 2015, 9065.
86. Hu, B.R., Martone, M.E., Jones, Y.Z., Liu, C.L., Protein aggregation after transient cerebral ischemia. J Neurosci. 20 (2000), 3191–3199.
87. Hu, B.R., Janelidze, S., Ginsberg, M.D., Busto, R., Perez-Pinzon, M., Sick, T.J., Siesjo, B.K., Liu, C.L., Protein aggregation after focal brain ischemia and reperfusion. J. Cereb. Blood Flow Metab. 21 (2001), 865–875.
88. Huang, Q., Wang, H., Perry, S.W., Figueiredo-Pereira, M.E., Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J. Biol. Chem. 288 (2013), 12161–12174.
89. Ihara, Y., Morishima-Kawashima, M., Nixon, R., The ubiquitin–proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb Perspect. Med., 2012, 2.
90. Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., Mueckler, M., Marshall, H., Donis-Keller, H., Crock, P., Rogers, D., Mikuni, M., Kumashiro, H., Higashi, K., Sobue, G., Oka, Y., Permutt, M.A., A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20 (1998), 143–148.
91. Jabouille, A., Delugin, M., Pineau, R., Dubrac, A., Soulet, F., Lhomond, S., Pallares-Lupon, N., Prats, H., Bikfalvi, A., Chevet, E., Touriol, C., Moenner, M., Glioblastoma invasion and cooption depend on IRE1alpha endoribonuclease activity. Oncotarget 6 (2015), 24922–24934.
92. Jin, S.M., Youle, R.J., The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 9 (2013), 1750–1757.
93. Kanekura, K., Ma, X., Murphy, J.T., Zhu, L.J., Diwan, A., Urano, F., IRE1 prevents endoplasmic reticulum membrane permeabilization and cell death under pathological conditions. Sci. Signal, 8, 2015, ra62.
94. Kang, M.J., Ryoo, H.D., Suppression of retinal degeneration in Drosophila by stimulation of ER-associated degradation. Proc. Natl. Acad. Sci. USA. 106 (2009), 17043–17048.
95. Keck, S., Nitsch, R., Grune, T., Ullrich, O., Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem. 85 (2003), 115–122.
96. Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., Abeliovich, H., Acevedo Arozena, A., Guidelines for the use and interpretation of assays for monitoring autophagy. 3rd ed Autophagy 12 (2016), 1–222.
97. Kozlowski, L., Garvis, S., Bedet, C., Palladino, F., The Caenorhabditis elegans HP1 family protein HPL-2 maintains ER homeostasis through the UPR and hormesis. Proc. Natl. Acad. Sci. USA. 111 (2014), 5956–5961.
98. Krajewska, M., Xu, L., Xu, W., Krajewski, S., Kress, C.L., Cui, J., Yang, L., Irie, F., Yamaguchi, Y., Lipton, S.A., Reed, J.C., Endoplasmic reticulum protein BI-1 modulates unfolded protein response signaling and protects against stroke and traumatic brain injury. Brain Res. 1370 (2011), 227–237.
99. Lehotsky, J., Racay, P., Pavlikova, M., Tatarkova, Z., Urban, P., Chomova, M., Kovalska, M., Kaplan, P., Cross-talk of intracellular calcium stores in the response to neuronal ischemia and ischemic tolerance. Gen. Physiol. Biophys. 28 Spec. No Focus (2009), F104–F114.
100. Lemarchant, S., Docagne, F., Emery, E., Vivien, D., Ali, C., Rubio, M., tPA in the injured central nervous system: different scenarios starring the same actor?. Neuropharmacology 62 (2012), 749–756.
101. Lemarchant, S., Pruvost, M., Hebert, M., Gauberti, M., Hommet, Y., Briens, A., Maubert, E., Gueye, Y., Feron, F., Petite, D., Mersel, M., do Rego, J.C., Vaudry, H., Koistinaho, J., Ali, C., Agin, V., Emery, E., Vivien, D., tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury. Neurobiol. Dis. 66 (2014), 28–42.
102. Lessing, D., Bonini, N.M., Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants. Nat. Rev. Genet. 10 (2009), 359–370.
103. Li, X., Chen, W., Zhang, L., Liu, W.B., Fei, Z., Inhibition of store-operated calcium entry attenuates MPP(+)-induced oxidative stress via preservation of mitochondrial function in PC12 cells: involvement of Homer1a. Plos One, 8, 2013, e83638.
104. Li, Z.Y., Liu, B., Yu, J., Yang, F.W., Luo, Y.N., Ge, P.F., Ischaemic postconditioning rescues brain injury caused by focal ischaemia/reperfusion via attenuation of protein oxidization. J. Int. Med. Res. 40 (2012), 954–966.
105. Liang, J., Yao, J., Wang, G., Wang, Y., Wang, B., Ge, P., Ischemic postconditioning protects neuronal death caused by cerebral ischemia and reperfusion via attenuating protein aggregation. Int. J. Med. Sci. 9 (2012), 923–932.
106. Lisbona, F., Rojas-Rivera, D., Thielen, P., Zamorano, S., Todd, D., Martinon, F., Glavic, A., Kress, C., Lin, J.H., Walter, P., Reed, J.C., Glimcher, L.H., Hetz, C., BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. Mol. Cell. 33 (2009), 679–691.
107. Liu, C.L., Ge, P., Zhang, F., Hu, B.R., Co-translational protein aggregation after transient cerebral ischemia. Neuroscience 134 (2005), 1273–1284.
108. Liu, X., Zhao, S., Liu, F., Kang, J., Xiao, A., Li, F., Zhang, C., Yan, F., Zhao, H., Luo, M., Luo, Y., Ji, X., Remote ischemic postconditioning alleviates cerebral ischemic injury by attenuating endoplasmic reticulum stress-mediated apoptosis. Transl. Stroke Res. 5 (2014), 692–700.
109. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., Kleihues, P., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114 (2007), 97–109.
110. Lu, S., Kanekura, K., Hara, T., Mahadevan, J., Spears, L.D., Oslowski, C.M., Martinez, R., Yamazaki-Inoue, M., Toyoda, M., Neilson, A., Blanner, P., Brown, C.M., Semenkovich, C.F., Marshall, B.A., Hershey, T., Umezawa, A., Greer, P.A., Urano, F., A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. Proc. Natl. Acad. Sci. USA. 111 (2014), E5292–E5301.
111. Malhotra, J.D., Kaufman, R.J., Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?. Antioxid. Redox Signal 9 (2007), 2277–2293.
112. Malhotra, J.D., Miao, H., Zhang, K., Wolfson, A., Pennathur, S., Pipe, S.W., Kaufman, R.J., Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. USA. 105 (2008), 18525–18530.
113. Mao, X.R., Crowder, C.M., Protein misfolding induces hypoxic preconditioning via a subset of the unfolded protein response machinery. Mol. Cell Biol. 30 (2010), 5033–5042.
114. Marciniak, S.J., Yun, C.Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., Harding, H.P., Ron, D., CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18 (2004), 3066–3077.
115. Martin, S., Lamb, H.K., Brady, C., Lefkove, B., Bonner, M.Y., Thompson, P., Lovat, P.E., Arbiser, J.L., Hawkins, A.R., Redfern, C.P., Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78. Br. J. Cancer 109 (2013), 433–443.
116. Martins, I., Galluzzi, L., Kroemer, G., Hormesis, cell death and aging. Aging 3 (2011), 821–828.
117. Mattson, M.P., Hormesis defined. Ageing Res. Rev. 7 (2008), 1–7.
118. Matus, S., Nassif, M., Glimcher, L.H., Hetz, C., XBP-1 deficiency in the nervous system reveals a homeostatic switch to activate autophagy. Autophagy 5 (2009), 1226–1228.
119. Maurel, M., Chevet, E., Tavernier, J., Gerlo, S., Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 39 (2014), 245–254.
120. Meller, R., Cameron, J.A., Torrey, D.J., Clayton, C.E., Ordonez, A.N., Henshall, D.C., Minami, M., Schindler, C.K., Saugstad, J.A., Simon, R.P., Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons. J. Biol. Chem. 281 (2006), 7429–7436.
121. Meller, R., Thompson, S.J., Lusardi, T.A., Ordonez, A.N., Ashley, M.D., Jessick, V., Wang, W., Torrey, D.J., Henshall, D.C., Gafken, P.R., Saugstad, J.A., Xiong, Z.G., Simon, R.P., Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism underlying rapid ischemic tolerance. J. Neurosci. 28 (2008), 50–59.
122. Mendes, C.S., Levet, C., Chatelain, G., Dourlen, P., Fouillet, A., Dichtel-Danjoy, M.L., Gambis, A., Ryoo, H.D., Steller, H., Mollereau, B., ER stress protects from retinal degeneration. Embo J. 28 (2009), 1296–1307.
123. Mercado, G., Valdes, P., Hetz, C., An ERcentric view of Parkinson׳s disease. Trends Mol. Med. 19 (2013), 165–175.
124. Mercado, G., Castillo, V., Vidal, R., Hetz, C., ER proteostasis disturbances in Parkinson׳s disease: novel insights. Front. Aging Neurosci., 7, 2015, 39.
125. Mollereau, B., Domingos, P.M., Photoreceptor differentiation in Drosophila: from immature neurons to functional photoreceptors. Dev. Dyn. 232 (2005), 585–592.
126. Mollereau, B., Cell death: what can we learn from flies? Editorial for the special review issue on Drosophila apoptosis. Apoptosis 14 (2009), 929–934.
127. Mollereau, B., Establishing links between ER-hormesis and cancer. Mol. Cell Biol. 33 (2013), 2372–2374.
128. Mollereau, B., Manie, S., Napoletano, F., Getting the better of ER stress. J. Cell. Commun. Signal 8 (2014), 311–321.
129. Mollereau, B., Cooling-induced ER stress is good for your brain. EBioMedicine 2 (2015), 482–483.
130. Moreno, J.A., Radford, H., Peretti, D., Steinert, J.R., Verity, N., Martin, M.G., Halliday, M., Morgan, J., Dinsdale, D., Ortori, C.A., Barrett, D.A., Tsaytler, P., Bertolotti, A., Willis, A.E., Bushell, M., Mallucci, G.R., Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485 (2012), 507–511.
131. Morimoto, R.I., Kline, M.P., Bimston, D.N., Cotto, J.J., The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 32 (1997), 17–29.
132. Morimoto, R.I., Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22 (2008), 1427–1438.
133. N, T.V., Sangwan, A., Sharma, B., Majid, A., Gk, R., Cerebral ischemic preconditioning: the road so far. Mol. Neurobiol., 2015 Epub ahead of print.
134. Nakka, V.P., Gusain, A., Raghubir, R., Endoplasmic reticulum stress plays critical role in brain damage after cerebral ischemia/reperfusion in rats. Neurotox. Res. 17 (2010), 189–202.
135. Narendra, D., Tanaka, A., Suen, D.F., Youle, R.J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell. Biol. 183 (2008), 795–803.
136. Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E.T., Vivien, D., Buisson, A., The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 7 (2001), 59–64.
137. NINDS, Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333 (1995), 1581–1587.
138. Nishitoh, H., Kadowaki, H., Nagai, A., Maruyama, T., Yokota, T., Fukutomi, H., Noguchi, T., Matsuzawa, A., Takeda, K., Ichijo, H., ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22 (2008), 1451–1464.
139. Ordonez, A.N., Jessick, V.J., Clayton, C.E., Ashley, M.D., Thompson, S.J., Simon, R.P., Meller, R., Rapid ischemic tolerance induced by adenosine preconditioning results in Bcl-2 interacting mediator of cell death (Bim) degradation by the proteasome. Int. J. Physiol. Pathophysiol. Pharmacol. 2 (2010), 36–44.
140. Osada, N., Kosuge, Y., Ishige, K., Ito, Y., Characterization of neuronal and astroglial responses to ER stress in the hippocampal CA1 area in mice following transient forebrain ischemia. Neurochem. Int. 57 (2010), 1–7.
141. Pang, P.T., Teng, H.K., Zaitsev, E., Woo, N.T., Sakata, K., Zhen, S., Teng, K.K., Yung, W.H., Hempstead, B.L., Lu, B., Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306 (2004), 487–491.
142. 2+ ATPase. J. Neurochem. 68 (1997), 1124–1134.
143. Parsons, J.T., Churn, S.B., DeLorenzo, R.J., Global ischemia-induced inhibition of the coupling ratio of calcium uptake and ATP hydrolysis by rat whole brain microsomal Mg(2+)/Ca(2+) ATPase. Brain Res. 834 (1999), 32–41.
144. Paschen, W., Gissel, C., Linden, T., Althausen, S., Doutheil, J., Activation of gadd153 expression through transient cerebral ischemia: evidence that ischemia causes endoplasmic reticulum dysfunction. Brain Res. Mol. Brain Res. 60 (1998), 115–122.
145. Paschen, W., Endoplasmic reticulum: a primary target in various acute disorders and degenerative diseases of the brain. Cell. Calcium 34 (2003), 365–383.
146. Paschen, W., Aufenberg, C., Hotop, S., Mengesdorf, T., Transient cerebral ischemia activates processing of xbp1 messenger RNA indicative of endoplasmic reticulum stress. J. Cereb. Blood Flow Metab. 23 (2003), 449–461.
147. Perez-Pinzon, M.A., Born, J.G., Centeno, J.M., Calcium and increase excitability promote tolerance against anoxia in hippocampal slices. Brain Res. 833 (1999), 20–26.
148. Perri, E.R., Thomas, C.J., Parakh, S., Spencer, D.M., Atkin, J.D., The unfolded protein response and the role of protein disulfide isomerase in neurodegeneration. Front. Cell. Dev. Biol., 3, 2015, 80.
149. Phillips, J.B., Williams, A.J., Adams, J., Elliott, P.J., Tortella, F.C., Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 31 (2000), 1686–1693.
150. Pluquet, O., Dejeans, N., Bouchecareilh, M., Lhomond, S., Pineau, R., Higa, A., Delugin, M., Combe, C., Loriot, S., Cubel, G., Dugot-Senant, N., Vital, A., Loiseau, H., Gosline, S.J., Taouji, S., Hallett, M., Sarkaria, J.N., Anderson, K., Wu, W., Rodriguez, F.J., Rosenbaum, J., Saltel, F., Fernandez-Zapico, M.E., Chevet, E., Posttranscriptional regulation of PER1 underlies the oncogenic function of IREalpha. Cancer Res. 73 (2013), 4732–4743.
151. Prabhu, A., Sarcar, B., Kahali, S., Shan, Y., Chinnaiyan, P., Targeting the unfolded protein response in glioblastoma cells with the fusion protein EGF-SubA. Plos One, 7, 2012, e52265.
152. Pyrko, P., Schonthal, A.H., Hofman, F.M., Chen, T.C., Lee, A.S., The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res. 67 (2007), 9809–9816.
153. Quik, M., Bordia, T., Zhang, D., Perez, X.A., Nicotine and nicotinic receptor drugs: potential for Parkinson׳s disease and drug-induced movement disorders. Int. Rev. Neurobiol. 124 (2015), 247–271.
154. Rasheva, V.I., Domingos, P.M., Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 14 (2009), 996–1007.
155. Rissanen, A., Sivenius, J., Jolkkonen, J., Prolonged bihemispheric alterations in unfolded protein response related gene expression after experimental stroke. Brain Res. 1087 (2006), 60–66.
156. Ritz, B., Ascherio, A., Checkoway, H., Marder, K.S., Nelson, L.M., Rocca, W.A., Ross, G.W., Strickland, D., Van Den Eeden, S.K., Gorell, J., Pooled analysis of tobacco use and risk of Parkinson disease. Arch. Neurol. 64 (2007), 990–997.
157. Roberts, G.G., Di Loreto, M.J., Marshall, M., Wang, J., DeGracia, D.J., Hippocampal cellular stress responses after global brain ischemia and reperfusion. Antioxid. Redox Signal 9 (2007), 2265–2275.
158. Rossi, D.J., Oshima, T., Attwell, D., Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 (2000), 316–321.
159. Rubinsztein, D.C., The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006), 780–786.
160. Rutkowski, D.T., Arnold, S.M., Miller, C.N., Wu, J., Li, J., Gunnison, K.M., Mori, K., Sadighi Akha, A.A., Raden, D., Kaufman, R.J., Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. Plos. Biol., 4, 2006, e374.
161. Rybnikova, E., Samoilov, M., Current insights into the molecular mechanisms of hypoxic pre- and postconditioning using hypobaric hypoxia. Front. Neurosci., 9, 2015, 388.
162. Ryoo, H.D., Domingos, P.M., Kang, M.J., Steller, H., Unfolded protein response in a Drosophila model for retinal degeneration. Embo J. 26 (2007), 242–252.
163. Ryoo, H.D., Steller, H., Unfolded protein response in Drosophila: why another model can make it fly. Cell Cycle 6 (2007), 830–835.
164. Ryoo, H.D., Drosophila as a model for unfolded protein response research. BMB Rep. 48 (2015), 445–453.
165. Rzechorzek, N.M., Connick, P., Patani, R., Selvaraj, B.T., Chandran, S., Hypothermic preconditioning of human cortical neurons requires proteostatic priming. EBioMedicine 2 (2015), 528–535.
166. Rzechorzek, N.M., Connick, P., Livesey, M.R., Borooah, S., Patani, R., Burr, K., Story, D., Wyllie, D.J.A., Hardingham, G.E., Chandran, S., Hypothermic preconditioning reverses tau ontogenesis in human cortical neurons and is mimicked by protein phosphatase 2A inhibition. EBioMedicine 3 (2016), 141–154.
167. Scortegagna, M., Kim, H., Li, J.L., Yao, H., Brill, L.M., Han, J., Lau, E., Bowtell, D., Haddad, G., Kaufman, R.J., Ronai, Z.A., Fine tuning of the UPR by the ubiquitin ligases Siah1/2. Plos. Genet., 10, 2014, e1004348.
168. Semenza, G.L., Life with oxygen. Science. 318 (2007), 62–64.
169. Sheng, R., Liu, X.Q., Zhang, L.S., Gao, B., Han, R., Wu, Y.Q., Zhang, X.Y., Qin, Z.H., Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning. Autophagy 8 (2012), 310–325.
170. Sheng, R., Qin, Z.H., The divergent roles of autophagy in ischemia and preconditioning. Acta Pharmacol. Sin. 36 (2015), 411–420.
171. Shpargel, K.B., Jalabi, W., Jin, Y., Dadabayev, A., Penn, M.S., Trapp, B.D., Preconditioning paradigms and pathways in the brain. Cleve Clin. J. Med. 75:Suppl. 2 (2008), S77–S82.
172. Sidhu, A., Miller, J.R., Tripathi, A., Garshott, D.M., Brownell, A.L., Chiego, D.J., Arevang, C., Zeng, Q., Jackson, L.C., Bechler, S.A., Callaghan, M.U., Yoo, G.H., Sethi, S., Lin, H.S., Callaghan, J.H., Tamayo-Castillo, G., Sherman, D.H., Kaufman, R.J., Fribley, A.M., Borrelidin induces the unfolded protein response in oral cancer cells and chop-dependent apoptosis. ACS Med. Chem. Lett. 6 (2015), 1122–1127.
173. Silva, R.M., Ries, V., Oo, T.F., Yarygina, O., Jackson-Lewis, V., Ryu, E.J., Lu, P.D., Marciniak, S.J., Ron, D., Przedborski, S., Kholodilov, N., Greene, L.A., Burke, R.E., CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J. Neurochem. 95 (2005), 974–986.
174. Song, B., Scheuner, D., Ron, D., Pennathur, S., Kaufman, R.J., Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Invest. 118 (2008), 3378–3389.
175. Soto, C., Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4 (2003), 49–60.
176. Srinivasan, R., Henley, B.M., Henderson, B.J., Indersmitten, T., Cohen, B.N., Kim, C.H., McKinney, S., Deshpande, P., Xiao, C., Lester, H.A., Smoking-relevant nicotine concentration attenuates the unfolded protein response in dopaminergic neurons. J. Neurosci. 36 (2016), 65–79.
177. Stetler, R.A., Leak, R.K., Gan, Y., Li, P., Zhang, F., Hu, X., Jing, Z., Chen, J., Zigmond, M.J., Gao, Y., Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog. Neurobiol. 114 (2014), 58–83.
178. Su, Y., Li, F., Endoplasmic reticulum stress in brain ischemia. Int. J. Neurosci., 2015, 1–11.
179. Sun, X., Liu, J., Crary, J.F., Malagelada, C., Sulzer, D., Greene, L.A., Levy, O.A., ATF4 protects against neuronal death in cellular Parkinson׳s disease models by maintaining levels of parkin. J. Neurosci. 33 (2013), 2398–2407.
180. Tai, H.C., Serrano-Pozo, A., Hashimoto, T., Frosch, M.P., Spires-Jones, T.L., Hyman, B.T., The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin–proteasome system. Am. J. Pathol. 181 (2012), 1426–1435.
181. Tajiri, S., Oyadomari, S., Yano, S., Morioka, M., Gotoh, T., Hamada, J.I., Ushio, Y., Mori, M., Ischemia-induced neuronal cell death is mediated by the endoplasmic reticulum stress pathway involving CHOP. Cell. Death Differ. 11 (2004), 403–415.
182. Tanahashi, N., Murakami, Y., Minami, Y., Shimbara, N., Hendil, K.B., Tanaka, K., Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J. Biol. Chem. 275 (2000), 14336–14345.
183. Truettner, J.S., Hu, K., Liu, C.L., Dietrich, W.D., Hu, B., Subcellular stress response and induction of molecular chaperones and folding proteins after transient global ischemia in rats. Brain Res. 1249 (2009), 9–18.
184. Tsujii, S., Ishisaka, M., Hara, H., Modulation of endoplasmic reticulum stress in Parkinson׳s disease. Eur. J. Pharmacol. 765 (2015), 154–156.
185. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P., Ron, D., Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287 (2000), 664–666.
186. Urano, F., Wolfram syndrome: diagnosis, management, and treatment. Curr. Diab. Rep., 16, 2016, 6.
187. Valdes, P., Mercado, G., Vidal, R.L., Molina, C., Parsons, G., Court, F.A., Martinez, A., Galleguillos, D., Armentano, D., Schneider, B.L., Hetz, C., Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc. Natl. Acad. Sci. USA. 111 (2014), 6804–6809.
188. Vidal, R.L., Figueroa, A., Court, F.A., Thielen, P., Molina, C., Wirth, C., Caballero, B., Kiffin, R., Segura-Aguilar, J., Cuervo, A.M., Glimcher, L.H., Hetz, C., Targeting the UPR transcription factor XBP1 protects against Huntington׳s disease through the regulation of FoxO1 and autophagy. Hum. Mol. Genet. 21 (2012), 2245–2262.
189. Voutilainen, M.H., Arumae, U., Airavaara, M., Saarma, M., Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson׳s disease. FEBS Lett. 589 (2015), 3739–3748.
190. Walter, P., Ron, D., The unfolded protein response: from stress pathway to homeostatic regulation. Science 334 (2011), 1081–1086.
191. Wang, M., Kaufman, R.J., Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature 529 (2016), 326–335.
192. Wang, S., Kaufman, R.J., The impact of the unfolded protein response on human disease. J. Cell Biol. 197 (2012), 857–867.
193. Watters, O., O׳Connor, J.J., A role for tumor necrosis factor-alpha in ischemia and ischemic preconditioning. J. Neuroinflamm., 8, 2011, 87.
194. Williams, A.J., Hale, S.L., Moffett, J.R., Dave, J.R., Elliott, P.J., Adams, J., Tortella, F.C., Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration. J. Cereb. Blood Flow Metab. 23 (2003), 75–87.
195. Williams, A.J., Berti, R., Dave, J.R., Elliot, P.J., Adams, J., Tortella, F.C., Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke 35 (2004), 1186–1191.
196. Williams, A.J., Myers, T.M., Cohn, S.I., Sharrow, K.M., Lu, X.C., Tortella, F.C., Recovery from ischemic brain injury in the rat following a 10 h delayed injection with MLN519. Pharmacol. Biochem. Behav. 81 (2005), 182–189.
197. Woo, C.W., Kutzler, L., Kimball, S.R., Tabas, I., Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B. Nat. Cell Biol. 14 (2012), 192–200.
198. Wu, J., Rutkowski, D.T., Dubois, M., Swathirajan, J., Saunders, T., Wang, J., Song, B., Yau, G.D., Kaufman, R.J., ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell. 13 (2007), 351–364.
199. Wu, L., Tian, Y.Y., Shi, J.P., Xie, W., Shi, J.Q., Lu, J., Zhang, Y.D., Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson׳s disease. Neurosci. Lett. 548 (2013), 50–55.
200. Yacoub, A., Hamed, H.A., Allegood, J., Mitchell, C., Spiegel, S., Lesniak, M.S., Ogretmen, B., Dash, R., Sarkar, D., Broaddus, W.C., Grant, S., Curiel, D.T., Fisher, P.B., Dent, P., PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res. 70 (2010), 1120–1129.
201. Yamashiro, K., Liu, R., Maeda, M., Hattori, N., Urabe, T., Induction and selective accumulation of mutant ubiquitin in CA1 pyramidal neurons after transient global ischemia. Neuroscience 147 (2007), 71–79.
202. Yuan, Y., Cao, P., Smith, M.A., Kramp, K., Huang, Y., Hisamoto, N., Matsumoto, K., Hatzoglou, M., Jin, H., Feng, Z., Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. Plos One, 6, 2011, e22354.
203. Zhang, L., Zhang, Z.G., Zhang, R.L., Lu, M., Adams, J., Elliott, P.J., Chopp, M., Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia. Stroke. 32 (2001), 2926–2931.
204. Zhang, X., Yuan, Y., Jiang, L., Zhang, J., Gao, J., Shen, Z., Zheng, Y., Deng, T., Yan, H., Li, W., Hou, W.W., Lu, J., Shen, Y., Dai, H., Hu, W.W., Zhang, Z., Chen, Z., Endoplasmic reticulum stress induced by tunicamycin and thapsigargin protects against transient ischemic brain injury: involvement of PARK2-dependent mitophagy. Autophagy 10 (2014), 1801–1813.
205. Zhu, X., Zelmer, A., Kapfhammer, J.P., Wellmann, S., Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress. FASEB J. 30 (2016), 624–634.